Category archives for OIRA
Around Memorial Day, OSHA set expectations in its regulatory agenda of what it would accomplish over the summer months. Now Labor Day is upon us and OSHA is 0 for 7 on the progress it said it would make on new worker safety regulations.
Three hours after I wrote this “The US Department of Labor has a plan to eliminate coal mine dust lung disease (a.k.a. black lung.) It’s been stuck in White House review for eight months, under the watch of a reg czar who promised timeliness of reviews,” they announced they were issuing the new rules.
The Obama Administration continues to let proposals to improve worker safety waste away in internal review.
Will President Obama’s new regulatory czar make good on his promise to conduct reviews of agency rules in a timely manner? The 90-day deadline will expire this week for the office’s review of the Labor Department’s final rule to protect coal miners from black lung disease.
Reporters were shut out during the shutdown of access to agency information. That situation didn’t stop two of them from continuing to report on deaths of workers in the U.S. mining industry.
The second annual report on US worker health and safety offers a review of activities and new policies at the federal scene, and a recap on the best reporting about it by the nation’s journalists.
OSHA’s recently released proposed rule on silica gives us a good opportunity to see if President Obama’s new regulatory czar will keep his promise for transparency in the rulemaking process.
A long-awaited proposal to protect 2 million workers from occupational silica exposure was announced today by OSHA.
Three months after a WV coal miner is killed on the job, the company decides to install safety equipment that could have saved his life.
The newly created Senate Judiciary Committee’s subcommittee on Oversight, Federal Rights and Agency Action held today its first hearing. Witnesses described the toll on public health and safety when the regulatory process is paralyzed by powerful interests and required analyses with no proven benefits.